Suthat Fucharoen

Q: What Schools Are Affiliated With Suthat Fucharoen

Suthat Fucharoen is affiliated with the following schools: Mahidol University, Imperial College London, Khon Kaen University, Stanford University

Suthat Fucharoen's AcademicInfluence.com Rankings

Suthat Fucharoen

Medical

#2557

World Rank

#2985

Historical Rank

Hematology

#35

World Rank

#41

Historical Rank

medical Degrees

Suthat Fucharoen

Biology

#10029

World Rank

#13310

Historical Rank

Biochemistry

#1560

World Rank

#1690

Historical Rank

biology Degrees

Download Badge

Medical
Biology

Suthat Fucharoen's Degrees

PhD Biomedical Sciences Mahidol University
Masters Biomedical Sciences Mahidol University
Bachelors Biomedical Sciences Mahidol University

Why Is Suthat Fucharoen Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Suthat Fucharoen's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

High levels of GDF15 in thalassemia suppress expression of the iron regulatory protein hepcidin (2007) (811)
On T2* Magnetic Resonance and Cardiac Iron (2011) (393)
Hemoglobinopathies in Southeast Asia. (1987) (299)
Hemoglobin H disease: not necessarily a benign disorder. (2003) (283)
Sustained dystrophin expression induced by peptide-conjugated morpholino oligomers in the muscles of mdx mice. (2008) (227)
Membrane phospholipid asymmetry in human thalassemia. (1998) (213)
Hemoglobinopathies in Southeast Asia: molecular biology and clinical medicine. (1997) (188)
Haemoglobinopathies in Southeast Asia (2011) (185)
A genome-wide association identified the common genetic variants influence disease severity in β0-thalassemia/hemoglobin E (2009) (177)
The effect of erythroid hyperplasia on iron balance. (1988) (168)
Hb H disease: clinical course and disease modifiers. (2009) (162)
Prenatal and postnatal diagnoses of thalassemias and hemoglobinopathies by HPLC. (1998) (160)
Restoration of hemoglobin A synthesis in erythroid cells from peripheral blood of thalassemic patients. (2000) (160)
International reproducibility of single breathhold T2* MR for cardiac and liver iron assessment among five thalassemia centers (2010) (146)
Thalassemia in SouthEast Asia: problems and strategy for prevention and control. (1992) (145)
Inherited Disorders of Hemoglobin (2006) (139)
Improvement in oxidative stress and antioxidant parameters in beta-thalassemia/Hb E patients treated with curcuminoids. (2010) (128)
Hydroxyurea increases hemoglobin F levels and improves the effectiveness of erythropoiesis in beta-thalassemia/hemoglobin E disease. (1996) (127)
A scoring system for the classification of β‐thalassemia/Hb E disease severity (2008) (126)
Clinical Manifestation of &bgr;-Thalassemia/Hemoglobin E Disease (2000) (125)
Severity differences in β‐thalassaemia/haemoglobin E syndromes: implication of genetic factors (1993) (116)
THALASSEMIA IN THAILAND * (1980) (109)
Platelet Inhibition by Nitrite Is Dependent on Erythrocytes and Deoxygenation (2012) (108)
Genetic Factors Affecting Clinical Severity in &bgr;-Thalassemia Syndromes (2000) (104)
A novel C-T transition within the distal CCAAT motif of the G gamma-globin gene in the Japanese HPFH: implication of factor binding in elevated fetal globin expression. (1990) (99)
Increased circulating activated endothelial cells, vascular endothelial growth factor, and tumor necrosis factor in thalassemia (2002) (99)
Clinical and hematologic aspects of hemoglobin E β-thalassemia (2000) (99)
Molecular and hematologic features of hemoglobin E heterozygotes with different forms of α-thalassemia in Thailand (2003) (95)
T‐type calcium channel blockade improves survival and cardiovascular function in thalassemic mice (2012) (92)
Pulmonary artery obstruction in thalassaemia. (1980) (90)
The unusual pathobiology of hemoglobin constant spring red blood cells. (1997) (90)
Flow cytometric quantitation of red blood cell vesicles in thalassemia (2004) (90)
Clinical trial of deferiprone iron chelation therapy in β‐thalassaemia/haemoglobin E patients in Thailand (2003) (86)
The molecular basis of beta-thalassemia in Thailand: application to prenatal diagnosis. (1990) (84)
Activated platelet‐derived microparticles in thalassaemia (2007) (79)
RNA repair restores hemoglobin expression in IVS2–654 thalassemic mice (2009) (79)
Repair of a splicing defect in erythroid cells from patients with beta-thalassemia/HbE disorder. (2002) (78)
T‐type calcium channel as a portal of iron uptake into cardiomyocytes of beta‐thalassemic mice (2011) (77)
Antitumor activity and mechanism of action of the iron chelator, Dp44mT, against leukemic cells (2009) (77)
ICSH recommendations for the measurement of Haemoglobin A2 (2012) (77)
Restoration of human beta-globin gene expression in murine and human IVS2-654 thalassemic erythroid cells by free uptake of antisense oligonucleotides. (2002) (71)
Clinical and hematologic aspects of hemoglobin E beta-thalassemia. (2000) (67)
Increased circulating platelet aggregates in thalassaemia. (1981) (66)
Rapid and simultaneous non‐radioactive method for detecting α‐thalassemia 1 (SEA type) and Hb Constant Spring genes (1994) (65)
A MULTI-CENTER STUDY IN ORDER TO FURTHER DEFINE THE MOLECULAR BASIS OF β-THALASSEMIA IN THAILAND, PAKISTAN, SRI LANKA, MAURITIUS, SYRIA, AND INDIA, AND TO DEVELOP A SIMPLE MOLECULAR DIAGNOSTIC STRATEGY BY AMPLIFICATION REFRACTORY MUTATION SYSTEM-POLYMERASE CHAIN REACTION (2001) (64)
Thalassaemia classification by neural networks and genetic programming (2007) (62)
The instability of the membrane skeleton in thalassemic red blood cells. (1995) (60)
ICSH recommendations for the measurement of Haemoglobin F (2012) (60)
Pulmonary thromboembolism in thalassemic patients. (1992) (58)
Graphene based aptasensor for glycated albumin in diabetes mellitus diagnosis and monitoring. (2016) (58)
Prenatal diagnosis of thalassemia and hemoglobinopathies in Thailand: experience from 100 pregnancies. (1991) (57)
Prenatal diagnosis of β‐thalassaemia by reverse dot‐blot hybridization (1999) (57)
A novel ochre mutation in the beta-thalassemia gene of a Thai. Identification by direct cloning of the entire beta-globin gene amplified using polymerase chain reactions. (1989) (56)
Major hematologic diseases in the developing world- new aspects of diagnosis and management of thalassemia, malarial anemia, and acute leukemia. (2001) (56)
Thalassemic erythrocytes inhibit in vitro growth of Plasmodium falciparum (1987) (54)
Prevention and control of thalassemia in Asia (2007) (54)
Epigallocatechin-3-gallate and epicatechin-3-gallate from green tea decrease plasma non-transferrin bound iron and erythrocyte oxidative stress. (2007) (54)
Iron metabolism in heterozygotes for hemoglobin E (HbE), α-thalassemia 1, or β-thalassemia and in compound heterozygotes for HbE/β-thalassemia (2008) (54)
Rapid diagnosis of thalassemias and other hemoglobinopathies by capillary electrophoresis system. (2008) (53)
Red cell deformability, splenic function and anaemia in thalassaemia (1999) (53)
Update in Laboratory Diagnosis of Thalassemia (2020) (51)
Iron chelation therapy in thalassemia major: a systematic review with meta-analyses of 1520 patients included on randomized clinical trials. (2011) (51)
α‐ and β‐Thalassemia in Thailand (1998) (50)
Impairment of Plasmodium falciparum growth in thalassemic red blood cells: further evidence by using biotin labeling and flow cytometry. (1999) (50)
Impaired parasite growth and increased susceptibility to phagocytosis of Plasmodium falciparum infected alpha-thalassemia or hemoglobin Constant Spring red blood cells. (1988) (50)
Iron-Chelating and Free-Radical Scavenging Activities of Microwave-Processed Green Tea in Iron Overload (2006) (50)
Curcumin contributes to in vitro removal of non-transferrin bound iron by deferiprone and desferrioxamine in thalassemic plasma. (2007) (49)
Downregulation of plasma miR-451 and miR-16 in Plasmodium vivax infection. (2015) (49)
Prevalence and Clinical Significance of Hepatitis C Virus Infection in Thai Patients with Thalassemia (2003) (48)
Renal Function in Adult Beta-Thalassemia/Hb E Disease (1998) (48)
A simple non-radioactive assay for hemoglobin E gene in prenatal diagnosis. (1994) (47)
Thalassemia and abnormal hemoglobin (2002) (47)
Effects of green tea on iron accumulation and oxidative stress in livers of iron-challenged thalassemic mice. (2010) (46)
A humanized mouse model for a common β0-thalassemia mutation (2005) (45)
A humanized BAC transgenic/knockout mouse model for HbE/β-thalassemia (2006) (44)
DNA polymorphisms of beta N- and beta E-globin genes in Thais. (1987) (43)
Beta-thalassemia associated with alpha-thalassemia in Thailand. (1988) (43)
Progress Toward the Control and Management of the Thalassemias. (2016) (43)
Lymphocyte subsets and specific T-cell immune response in thalassemia. (2000) (42)
Reverse dot‐blot detection of Thai β‐thalassaemia mutations (1995) (42)
Characterizations and proteome analysis of platelet-free plasma-derived microparticles in β-thalassemia/hemoglobin E patients. (2012) (42)
Targeted modification of a human beta-globin locus BAC clone using GET Recombination and an I-Scei counterselection cassette. (2003) (41)
Molecular basis of HbE-beta-thalassemia and the origin of HbE in northeast Thailand: identification of one novel mutation using amplified DNA from buffy coat specimens. (1990) (41)
Serum levels of tumor necrosis factor-alpha, interleukin-1, and interferon-gamma in beta(o)-thalassemia/HbE and their clinical significance. (1999) (41)
Expression of microRNA-451 in normal and thalassemic erythropoiesis (2010) (41)
Variable severity of Southeast Asian beta 0-thalassemia/Hb E disease. (1987) (41)
Iron metabolism in heterozygotes for hemoglobin E (HbE), alpha-thalassemia 1, or beta-thalassemia and in compound heterozygotes for HbE/beta-thalassemia. (2008) (41)
Multicenter Study of the Molecular Basis of Thalassemia Intermedia in Different Ethnic Populations (2007) (40)
Association of the Long Non-coding RNA Steroid Receptor RNA Activator (SRA) with TrxG and PRC2 Complexes (2015) (40)
Detection of α‐thalassemia‐1 (Southeast Asian type) and its application for prenatal diagnosis (1995) (39)
Presumptive diagnosis of common haemoglobinopathies in Southeast Asia using a capillary electrophoresis system (2011) (39)
Hemin: A Possible Cause of Oxidative Stress in Blood Circulation of β-Thalassemia/Hemoglobin E Disease (2003) (39)
Gut leakage enhances sepsis susceptibility in iron-overloaded β-thalassemia mice through macrophage hyper-inflammatory responses. (2020) (39)
Reversal of cardiac iron loading and dysfunction in thalassemic mice by curcuminoids. (2011) (39)
Liver injury due to iron overload in thalassemia: histopathologic and ultrastructural studies (1996) (38)
Differences between two types of Hb H disease, alpha-thalassemia 1/alpha-thalassemia 2 and alpha-thalassemia 1/Hb constant spring. (1987) (38)
Heart rate variability in beta‐thalassemia patients (2009) (37)
Increased oxidative metabolism is associated with erythroid precursor expansion in β0-thalassaemia/Hb E disease. (2011) (37)
Combined Iron Chelator and Antioxidant Exerted Greater Efficacy on Cardioprotection Than Monotherapy in Iron-Overloaded Rats (2016) (37)
Calibration of myocardial T2 and T1 against iron concentration (2014) (36)
Concomitant inheritance of α‐thalassemia in β°‐thalassemia/hb e disease (1985) (36)
Hematologic and biosynthetic studies in homozygous hemoglobin Constant Spring. (1984) (35)
Coinheritance of the different copy numbers of α-globin gene modifies severity of β-thalassemia/Hb E disease (2008) (35)
Effect of green tea on iron status and oxidative stress in iron-loaded rats. (2008) (35)
Imbalanced globin chain synthesis determines erythroid cell pathology in thalassemic mice (2009) (35)
Fetal hemoglobin regulation in β-thalassemia: heterogeneity, modifiers and therapeutic approaches (2016) (35)
UGT1A6 genotype-related pharmacokinetics of deferiprone (L1) in healthy volunteers. (2008) (35)
Disorders of Hemoglobin: Hemoglobin E Disorders (2009) (34)
Labdane diterpenes from the aerial parts of Curcuma comosa enhance fetal hemoglobin production in an erythroid cell line. (2010) (34)
Thalassemia in Southeast Asia: Determination of Different Degrees of Severity of Anemia in Thalassemia a (1985) (34)
Reduced deformability of thalassemic erythrocytes and erythrocytes with abnormal hemoglobins and relation with susceptibility to Plasmodium falciparum invasion. (1992) (34)
A Flow Cytometric Analysis of the Inhibition of Platelet Reactivity Due to Nitrite Reduction by Deoxygenated Erythrocytes (2014) (33)
Increased urinary 1,N6-ethenodeoxyadenosine and 3,N4-ethenodeoxycytidine excretion in thalassemia patients: markers for lipid peroxidation-induced DNA damage. (2008) (33)
Screening for the carriers of thalassemias and abnormal hemoglobins at the community level. (2002) (33)
Dual T‐type and L‐type calcium channel blocker exerts beneficial effects in attenuating cardiovascular dysfunction in iron‐overloaded thalassaemic mice (2016) (32)
Enhanced erythroid cell differentiation in hypoxic condition is in part contributed by miR-210. (2013) (32)
Efficacy of curcuminoids in alleviation of iron overload and lipid peroxidation in thalassemic mice. (2009) (32)
Mitochondrial calcium uniporter blocker prevents cardiac mitochondrial dysfunction induced by iron overload in thalassemic mice (2012) (32)
Genetic modifiers of Hb E/β0 thalassemia identified by a two-stage genome-wide association study (2010) (32)
A randomized phase I/II trial of HQK‐1001, an oral fetal globin gene inducer, in β‐thalassaemia intermedia and HbE/β‐thalassaemia (2013) (32)
Genetic modifiers in hemoglobinopathies. (2008) (32)
β‐Globin gene cluster polymorphisms are strongly associated with severity of HbE/β0‐thalassemia (2007) (32)
Fetal globin gene inducers: novel agents and new potential (2010) (32)
Red cell and plasma calcium, copper and zinc in beta-thalassemia/hemoglobin E. (1991) (32)
Treatment of β-Thalassemia/Hemoglobin E with Antioxidant Cocktails Results in Decreased Oxidative Stress, Increased Hemoglobin Concentration, and Improvement of the Hypercoagulable State (2015) (31)
Increased phagocytosis of Plasmodium falciparum-infected erythrocytes with haemoglobin E by peripheral blood monocytes. (1986) (31)
The effects of vitamin E on platelet activity in β‐thalassaemia patients (2003) (31)
Activation of monocytes for the immune clearance of red cells in β°‐thalassaernia/HbE (1993) (31)
Current and future treatment strategies for iron overload cardiomyopathy. (2015) (31)
Decreased sensitivity of artesunate and chloroquine of Plasmodium falciparum infecting hemoglobin H and/or hemoglobin constant spring erythrocytes. (1989) (31)
Increased serum levels of macrophage colony‐stimulating factor (M–CSF) in α‐and β‐thalassaemia syndromes: correlation with anaemia and monocyte activation (1996) (30)
Molecular and hematological characterization of Hb Tak and Hb Pyrgos in Thailand. (1997) (30)
Quantitative determination of ortho- and meta-tyrosine as biomarkers of protein oxidative damage in β-thalassemia (2007) (29)
Circulating microRNAs in malaria infection: bench to bedside (2017) (29)
A mechanism of ineffective erythropoiesis in β-thalassemia/Hb E disease (2010) (29)
Molecular basis of beta-thalassemia in the Maldives. (1998) (29)
Parallel assessment of globin lentiviral transfer in induced pluripotent stem cells and adult hematopoietic stem cells derived from the same transplanted β‐thalassemia patient (2013) (29)
Green tea extract modulates oxidative tissue injury in beta-thalassemic mice by chelation of redox iron and inhibition of lipid peroxidation. (2018) (29)
Enhanced activation of autophagy in β-thalassemia/Hb E erythroblasts during erythropoiesis (2011) (28)
Effects of iron overload, an iron chelator and a T‐Type calcium channel blocker on cardiac mitochondrial biogenesis and mitochondrial dynamics in thalassemic mice (2017) (28)
Molecular analysis of β‐thalassemia in South Vietnam (2002) (28)
Increased erythropoiesis of β‐thalassaemia/Hb E proerythroblasts is mediated by high basal levels of ERK1/2 activation (2009) (28)
Hypoxaemia and the effect of aspirin in thalassaemia. (1981) (27)
Accumulation of lipid peroxidation‐derived DNA lesions in iron‐overloaded thalassemic mouse livers: Comparison with levels in the lymphocytes of thalassemia patients (2009) (27)
Erythropoietin and IGF-1 signaling synchronize cell proliferation and maturation during erythropoiesis (2015) (27)
Effects of Combined UDP-Glucuronosyltransferase (UGT) 1A1*28 and 1A6*2 on Paracetamol Pharmacokinetics in β-Thalassemia/HbE (2006) (27)
Molecular Screening of the Hbs Constant Spring (codon 142, TAA>CAA, α2) and PAKSÉ (codon 142, TAA>TAT, α2) Mutations in Thailand (2010) (27)
In vivo and in vitro studies of fetal hemoglobin induction by hydroxyurea in beta-thalassemia/hemoglobin E patients. (2005) (27)
Insight into the Peopling of Mainland Southeast Asia from Thai Population Genetic Structure (2013) (26)
Cardiac involvement in beta-thalassemia/hemoglobin E disease: clinical and hemodynamic findings. (1990) (26)
Flow cytometric immunophenotyping of lymphocyte subsets in samples that contain a high proportion of non-lymphoid cells. (1994) (26)
A humanized mouse model for a common beta0-thalassemia mutation. (2005) (26)
Detection of haemoglobin variants and inference of their functional properties using complete oxygen dissociation curve measurements (2001) (26)
Quantitative analysis of Hb Bart’s in cord blood by capillary electrophoresis system (2011) (26)
Reduced PU.1 expression underlies aberrant neutrophil maturation and function in β-thalassemia mice and patients. (2017) (26)
Morphological alterations and apoptosis of endothelial cells induced by thalassemic serum in vitro. (1997) (26)
Selective enzymatic amplification of alpha 2-globin DNA for detection of the hemoglobin Constant Spring mutation. (1989) (25)
Molecular basis of alpha (0)-thalassemia in northeast of Thailand. (1995) (25)
Coinheritance of the different copy numbers of alpha-globin gene modifies severity of beta-thalassemia/Hb E disease. (2008) (25)
Hydroxyurea responses and fetal hemoglobin induction in β-thalassemia/HbE patients’ peripheral blood erythroid cell culture (2006) (25)
Glycated Albumin Measurement Using an Electrochemical Aptasensor for Screening and Monitoring of Diabetes Mellitus (2019) (25)
HbE/β-Thalassemia and Oxidative Stress: The Key to Pathophysiological Mechanisms and Novel Therapeutics. (2017) (25)
Intracranial extramedullary hematopoiesis inducing epilepsy in a patient with beta-thalassemia--hemoglobin E. (1985) (25)
Association of SNP in exon 1 of HBS1L with hemoglobin F level in β0-thalassemia/hemoglobin E (2008) (25)
Elevated F2-isoprostanes in thalassemic patients. (2007) (24)
Identification of five rare mutations including a novel frameshift mutation causing β0-thalassemia in Thai patients with β0-thalassemia/hemoglobin E disease (1992) (24)
Early detection of cardiac involvement in thalassemia: From bench to bedside perspective. (2013) (24)
A humanized BAC transgenic/knockout mouse model for HbE/beta-thalassemia. (2006) (24)
Genetic polymorphisms and implications for human diseases. (2007) (23)
Homozygous haemoglobin constant spring: A need for revision of concept (2004) (23)
A combination of an iron chelator with an antioxidant exerts greater efficacy on cardioprotection than monotherapy in iron-overload thalassemic mice (2018) (23)
Pathogen-Associated Molecules from Gut Translocation Enhance Severity of Cecal Ligation and Puncture Sepsis in Iron-Overload β-Thalassemia Mice (2020) (22)
Platelet activation and platelet–leukocyte interaction in β-thalassemia/hemoglobin E patients with marked nucleated erythrocytosis (2012) (22)
Cold exposure down-regulates zebrafish hematopoiesis. (2010) (22)
GENETIC BASIS, PATHOPHYSIOLOGY AND DIAGNOSIS (2014) (22)
Molecular analysis of globin gene expression in different thalassaemia disorders: individual variation of βE pre‐mRNA splicing determine disease severity (2011) (22)
Heart rate variability in -thalassemic mice (2007) (22)
Increase in non-transferrin bound iron and the oxidative stress status in epilepsy patients treated using valproic acid monotherapy. (2011) (22)
Effect of coenzyme Q10 as an antioxidant in β‐thalassemia/Hb E patients (2005) (21)
Prenatal diagnosis of beta-thalassaemia by reverse dot-blot hybridization. (1999) (21)
Hemoglobin constant spring in bangkok: Molecular screening by selective enzymatic amplification of the α2‐globin gene (1991) (21)
New updating into hemoglobinopathies (2012) (21)
Molecular and hematological characterization of HbE heterozygote with alpha-thalassemia determinant. (1997) (21)
EF Bart's disease: Interaction of the abnormal α‐ and β‐globin genes (1988) (21)
Hydration of red cells in α and β thalassemias differs : a useful approach to distinguish between these red cell phenotypes (1994) (21)
Calcium channels and iron uptake into the heart. (2011) (21)
Glutathione Redox System in β-Thalassemia/Hb E Patients (2013) (20)
Studies of hemoglobin Bart and deletion of alpha-globin genes from cord blood in Thailand. (1987) (20)
Impaired bone formation and osteopenia in heterozygous βIVSII-654 knockin thalassemic mice (2011) (20)
Hemoglobin dhonburi α2β2 126 (H4) Val → Gly: A new unstable β variant producing a β‐thalassemia intermedia phenotype in association with β°‐Thalassemia (1990) (20)
Insertion of common mutations into the human beta-globin locus using GET Recombination and an EcoRI endonuclease counterselection cassette. (2003) (20)
Microparticles from splenectomized β-thalassemia/HbE patients play roles on procoagulant activities with thrombotic potential (2017) (20)
Severe infection in thalassemia: a prospective study. (1987) (20)
Rapid diagnosis of alpha-thalassemia by melting curve analysis. (2010) (19)
The effects of vitamin E on platelet activity in beta-thalassaemia patients. (2003) (19)
A multi-center study in order to further define the molecular basis of beta-thalassemia in Thailand, Pakistan, Sri Lanka, Mauritius, Syria, and India, and to develop a simple molecular diagnostic strategy by amplification refractory mutation system-polymerase chain reaction. (2001) (19)
Elevated erythropoietin and cytokines levels are related to impaired reticulocyte maturation in thalassemic patients. (2015) (19)
HB Q-Thailand [α74(EF3)ASP→HIS] : gene organization, molecular structure, and DNA diagnosis (1992) (19)
The inherited diseases of haemoglobin are an emerging global health burden (2012) (19)
Ultrasonographic method for detection of haemoglobin Bart's hydrops fetalis in the second trimester of pregnancy (1990) (19)
Genetic Analysis of Candidate Modifier Polymorphisms in Hb E‐β0‐Thalassemia Patients (2005) (19)
Chromosomal microarray analysis in a cohort of underrepresented population identifies SERINC2 as a novel candidate gene for autism spectrum disorder (2017) (18)
The molecular basis of alpha-thalassemia in Thailand. (1992) (18)
Nitric oxide and caspase 3 mediated cytokine induced apoptosis in acute leukemia. (2011) (18)
Ferric iron uptake into cardiomyocytes of β-thalassemic mice is not through calcium channels (2013) (18)
Increased susceptibility to dextran sulfate-induced mucositis of iron-overload β-thalassemia mice, another endogenous cause of septicemia in thalassemia (2021) (18)
Clinical and methodological factors affecting non-transferrin-bound iron values using a novel fluorescent bead assay (2016) (18)
Characterising private and shared signatures of positive selection in 37 Asian populations (2017) (18)
Simultaneous PCR detection of beta - thalassemia and alpha - thalassemia 1 (SEA type) in prenatal diagnosis of complex thalassemia syndrome. (2001) (18)
Decrement in Cellular Iron and Reactive Oxygen Species, and Improvement of Insulin Secretion in a Pancreatic Cell Line Using Green Tea Extract (2019) (17)
Increased serum levels of macrophage colony-stimulating factor (M-CSF) in alpha- and beta-thalassaemia syndromes: correlation with anaemia and monocyte activation. (1996) (17)
Role of alternatively spliced beta E-globin mRNA on clinical severity of beta-thalassemia/hemoglobin E disease. (1995) (17)
Characterisation of a novel oral iron chelator: 1‐(N‐Acetyl‐6‐Aminohexyl)‐3‐Hydroxy‐2‐Methylpyridin‐4‐one (2015) (17)
Molecular Epidemiology of Hemoglobinopathies in Cambodia (2016) (17)
Reverse dot-blot detection of Thai beta-thalassaemia mutations. (1995) (17)
Deaths in beta-thalassemia/Hb E patients secondary to infections. (1987) (16)
Iron distribution and histopathological characterization of the liver and heart of β-thalassemic mice with parenteral iron overload: Effects of deferoxamine and deferiprone. (2014) (16)
Cytokine-Induced Apoptosis of Beta-Thalassemia/Hemoglobin E Erythroid Progenitor Cells via Nitric Oxide-Mediated Process in vitro (2011) (16)
Cardiac pathology in 47 patients with beta thalassaemia/haemoglobin E. (1984) (16)
Beta-globin gene cluster polymorphisms are strongly associated with severity of HbE/beta(0)-thalassemia. (2007) (16)
Role of curcuminoids in ameliorating oxidative modification in β-thalassemia/Hb E plasma proteome. (2013) (16)
A simple non radioactive method for detecting beta-thalassemia/hbe disease: application to prenatal diagnosis. (1995) (16)
Detection and structural analysis of abnormal hemoglobins found in Thailand. (1999) (16)
Effects of Iron Chelators on Pulmonary Iron Overload and Oxidative Stress in β-Thalassemic Mice (2015) (16)
Three-base deletion in exon 3 of the beta-globin gene produced a novel variant (beta gunma) with a thalassemia-like phenotype [letter] (1990) (16)
Platelet inhibition and increased phosphorylated vasodilator-stimulated phosphoprotein following sodium nitrite inhalation. (2017) (16)
Detection of alpha-thalassemia-1 (Southeast Asian type) and its application for prenatal diagnosis. (1995) (16)
Standardization on laboratory diagnosis of thalassemia and abnormal hemoglobin. (1999) (16)
Defective spectrin dimer self‐association in thalassemic red cells (1987) (15)
BET bromodomain inhibition rescues erythropoietin differentiation of human erythroleukemia cell line UT7. (2012) (15)
Heart rate variability in beta-thalassemic mice. (2007) (15)
Comparison of erythrocyte antioxidative enzyme activities between two types of haemoglobin H disease. (1986) (15)
Plasma microRNA-451 as a novel hemolytic marker for β0-thalassemia/HbE disease (2017) (15)
Determination for different severity of anemia in thalassemia: concordance and discordance among sib pairs. (1984) (15)
Hepcidin and 1,25(OH)2D3 effectively restore Ca2+ transport in β-thalassemic mice: reciprocal phenomenon of Fe2+ and Ca2+ absorption. (2016) (15)
The reduction of cholesteryl linoleate in lipoproteins: an index of clinical severity in β-thalassemia/Hb E (2006) (15)
Effect of Tumor Necrosis Factor-Alpha on Erythropoietin- and Erythropoietin Receptor-Induced Erythroid Progenitor Cell Proliferation in β-Thalassemia/Hemoglobin E Patients (2015) (15)
Therapeutic fetal-globin inducers reduce transcriptional repression in hemoglobinopathy erythroid progenitors through distinct mechanisms. (2016) (14)
Prenatal diagnosis of βthalassaemia by reverse dot‐blot hybridization (1999) (14)
Molecular mechanisms of thalassemia in southeast Asia. (1995) (14)
Erythroblast‐ and erythrocyte‐bound antibodies in α and β thalassaemia syndromes * (1991) (14)
&THALASSEUIA ASSOCIATED WITH a -THAlASSEMIA IN THAILAND (1988) (14)
miR-144 regulates oxidative stress tolerance of thalassemic erythroid cell via targeting NRF2 (2019) (14)
Phenotypic characterization of circulating CD4/CD8 T-lymphocytes in β-thalassemia patients. (2014) (14)
Lipid fluidity at different regions in LDL and HDL of beta-thalassemia/Hb E patients. (2006) (14)
Erythrocyte volume and haemoglobin concentration in haemoglobin H disease: discrimination between the two genotypes. (1992) (14)
Ultrastructure and cell cycle distribution of erythropoietic cells in heterozygotes and homozygotes for haemoglobin E (1984) (14)
Cytoadherence between endothelial cells and P. falciparum infected and noninfected normal and thalassemic red blood cells (2006) (14)
Post-mortem study of the association between cardiac iron and fibrosis in transfusion dependent anaemia (2017) (14)
Thalassemia: Pathophysiology and management. Part A (1988) (14)
Lymphocytes in β‐thalassemia/HbE: subpopulations and mitogen responses (1996) (14)
Pharmaco/ferrokinetic-related pro-oxidant activity of deferiprone in β-thalassemia (2009) (14)
MiR-155 enhances phagocytic activity of β-thalassemia/HbE monocytes via targeting of BACH1 (2017) (14)
The Origin and Composition of Korean Ethnicity Analyzed by Ancient and Present-Day Genome Sequences (2020) (14)
ICSH recommendations for assessing automated high‐performance liquid chromatography and capillary electrophoresis equipment for the quantitation of HbA2 (2015) (13)
Hemoglobin E Prevalence among Ethnic Groups Residing in Malaria-Endemic Areas of Northern Thailand and Its Lack of Association with Plasmodium falciparum Invasion In Vitro (2016) (13)
Consumption of a green tea extract-curcumin drink decreases blood urea nitrogen and redox iron in β-thalassemia patients. (2020) (13)
Activation of monocytes for the immune clearance of red cells in beta zero-thalassaemia/HbE. (1993) (13)
Hypoxemia in thalassemia. (1982) (13)
Molecular characterization and nonradioactive detection of beta-thalassemia in Malaysia. (1990) (13)
Molecular basis and hematological features of hemoglobin variants in Southern Thailand (2010) (13)
Effects of iron overload condition on liver toxicity and hepcidin/ferroportin expression in thalassemic mice. (2016) (13)
Abnormal red blood cell morphological changes in thalassaemia associated with iron overload and oxidative stress (2019) (13)
Inhibitory effect of β°-thalassaemia/haemoglobin E erythrocytes on Plasmodium falciparum growth in vitro (1987) (13)
Thai Gγ(Aγ δβ)°-Thalassemia and its Interaction with a Single γ-GLOBIN Gene on a Chromosome Carrying β°-Thalassemia (1990) (13)
Clinical Manifestation of -Thalassemia/Hemoglobin E Disease (2000) (13)
Identification of Hb Lepore-Washington-Boston in association with Hb E [beta 26(B8)Glu----Lys] in a Thai female. (1987) (12)
Maternal uniparental disomy of chromosome 16 resulting in hemoglobin Bart’s hydrops fetalis (2008) (12)
Alpha-thalassemia incidence in southern Thailand by restriction endonuclease analysis of globin DNA from placental blood at Songklanagarind Hospital. (1997) (12)
Pharmacokinetics of Deferiprone in Patients with β-Thalassaemia : Impact of Splenectomy and Iron Status. (2011) (12)
Effect of coenzyme Q10 as an antioxidant in beta-thalassemia/Hb E patients. (2005) (12)
Compound heterozygosity for Hb Korle-Bu (β73; Asp-Asn) and Hb E (β26; Glu-Lys) with a 3.7-kb deletional α-thalassemia in Thai patients (2002) (12)
A study of infective episodes in patients with beta-thalassemia/Hb E disease in Thailand. (1987) (12)
Asymmetrically primed selective amplification/temperature shift fluorescence polymerase chain reaction to detect the hemoglobin Constant Spring mutation. (1991) (12)
Proteomic analysis of hemoglobin H-constant spring (Hb H-CS) erythroblasts. (2012) (12)
Discrimination of various thalassemia syndromes and iron deficiency and utilization of reticulocyte measurements in monitoring response to iron therapy. (2015) (12)
Paraoxonase and platelet-activating factor acetylhydrolase activities in lipoproteins of β-thalassemia/hemoglobin E patients (2007) (12)
Decreased nitrite levels in erythrocytes of children with β-thalassemia/hemoglobin E. (2013) (12)
In vitro antimicrobial activity of volatile organic compounds from Muscodor crispans against the pathogenic oomycete Pythium insidiosum. (2012) (12)
Evaluating the performance of automated UV enzymatic assay for screening of glucose 6‐phosphate dehydrogenase deficiency (2018) (12)
Elevated levels of miR-210 correlate with anemia in β-thalassemia/HbE patients (2016) (12)
The prevalence of alpha-thalassemia amongst Tai and Mon-Khmer ethnic groups residing in northern Thailand: A population-based study (2016) (12)
Platelet hyperactivity in thalassemia patients with elevated tricuspid regurgitant velocity and the association with hemolysis. (2015) (12)
Combined iron chelator and T‐type calcium channel blocker exerts greater efficacy on cardioprotection than monotherapy in iron‐overload thalassemic mice (2018) (11)
Beta-thalassemia in Thailand. (1990) (11)
Validation of the immunochromatographic strip for α-thalassemia screening: a multicenter study. (2015) (11)
Concomitant inheritance of alpha-thalassemia in beta 0- thalassemia/Hb E disease. (1985) (11)
Thalassemia : pathophysiology and management (1988) (11)
Transplantation of Macaca cynomolgus iPS-derived hematopoietic cells in NSG immunodeficient mice (2015) (11)
Genetic variation of Krüppel-like factor 1 (KLF1) and fetal hemoglobin (HbF) levels in β0-thalassemia/HbE disease (2018) (11)
Differential plasma proteome profiles of mild versus severe β-thalassemia/Hb E (2013) (11)
Detection of ζ‐globin chains in the cord blood by ELISA (enzyme‐linked immunosorbent assay): Rapid screening for α‐thalassemia 1 (Southeast Asian type) (1998) (11)
Noninvasive Prenatal Diagnosis for Hemoglobin Bart’s Hydrops Fetalis (2005) (11)
Cardiac complications in beta-thalassemia: From mice to men (2017) (11)
Presence of immunoglobulins, C3 and cytolytic C5b‐9 complement components on the surface of erythrocytes from patients with β‐thalassaemia/HbE disease (1997) (11)
Combined treatment of 3-hydroxypyridine-4-one derivatives and green tea extract to induce hepcidin expression in iron-overloaded β-thalassemic mice (2015) (11)
Extracting predictive SNPs in Crohn's disease using a vacillating genetic algorithm and a neural classifier in case-control association studies (2014) (11)
Restoration of correct βIVS2-654-globin mRNA splicing and HbA production by engineered U7 snRNA in β-thalassaemia/HbE erythroid cells (2019) (10)
Molecular basis of beta-thalassemia in Thailand: analysis of beta-thalassemia mutations using the polymerase chain reaction. (1989) (10)
Efficacy of 1-(N-acetyl-6-aminohexyl)-3-hydroxypyridin- 4-one (CM1) in treatment of iron-loaded hepatocyte cultures (2012) (10)
Evaluation of a novel oral iron chelator 1-(N-acetyl-6-aminohexyl)-3-hydroxypyridin-4-one (CM1) for treatment of iron overload in mice (2013) (10)
Clinical and hematologic manifestations of AE Bart disease. (1987) (10)
Visual genotyping of thalassemia by using pyrrolidinyl peptide nucleic acid probes immobilized on carboxymethylcellulose-modified paper and enzyme-induced pigmentation (2020) (10)
A reduced curcuminoid analog as a novel inducer of fetal hemoglobin (2013) (10)
Rapid differentiation of five common α-thalassemia genotypes by polymerase chain reaction☆ (2001) (10)
Dengue virus infection of erythroid precursor cells is modulated by both thalassemia trait status and virus adaptation. (2014) (10)
Molecular characterization of thalassemia intermedia with homozygous Hb Malay and Hb Malay/HbE in Thai patients. (2001) (10)
Insertion of modifications in the β-globin locus using GET recombination with single-stranded oligonucleotides and denatured PCR fragments (2003) (10)
Identification of five rare mutations including a novel frameshift mutation causing beta zero-thalassemia in Thai patients with beta zero-thalassemia/hemoglobin E disease. (1992) (10)
Role of NF‐κ B in regulation of apoptosis of erythroid progenitor cells (2005) (10)
Calibration of myocardial iron concentration against T2-star Cardiovascular Magnetic Resonance (2009) (10)
Hydration of red cells in alpha and beta thalassemias differs. A useful approach to distinguish between these red cell phenotypes. (1994) (9)
Molecular heterogeneity of beta-thalassemia in Thailand. (1992) (9)
An in vivo model for analysis of developmental erythropoiesis and globin gene regulation (2014) (9)
A comprehensive ethnic-based analysis of alpha thalassaemia allelle frequency in northern Thailand (2017) (9)
Ineffective Erythropoiesis in Haemoglobin Eβ ‐thalassaemia: an Electron Microscope Study (1981) (9)
Brain pathology in 6 fatal cases of post-transfusion hypertension, convulsion and cerebral hemorrhage syndrome. (1992) (9)
Anti-Platelet Aggregation and Anti-Cyclooxygenase Activities for a Range of Coffee Extracts (Coffea arabica) (2020) (9)
Oxidative stress and antioxidative enzymes in hemoglobin H disease. (1987) (9)
Diagnosis of common hemoglobinopathies among South East Asian population using capillary isoelectric focusing system (2017) (9)
UNC0638 induces high levels of fetal hemoglobin expression in β-thalassemia/HbE erythroid progenitor cells (2020) (9)
Hypermethylation of 28S ribosomal RNA in β-thalassemia trait carriers. (2017) (9)
Number and maturation of reticulocytes in various genotypes of thalassaemia as assessed by flow cytometry. (1994) (9)
The molecular basis of AE-Bart's disease. (1989) (9)
Effect of a novel oral active iron chelator: 1-(N-acetyl-6-aminohexyl)-3-hydroxy-2-methylpyridin-4-one (CM1) in iron-overloaded and non-overloaded mice. (2014) (9)
A study of thalassemia associated with pregnancy. (1988) (9)
Mitochondrial Changes in β0-Thalassemia/Hb E Disease (2016) (9)
Pharmacokinetics of Deferiprone in Patients with β-Thalassaemia (2011) (9)
β‐Thalassemia in Thailand a (1990) (9)
Nondeletional type of hereditary persistence of fetal haemoglobin: molecular characterization of three unrelated Thai HPFH (1994) (8)
Engineered U7 snRNA mediates sustained splicing correction in erythroid cells from β-thalassemia/HbE patients. (2018) (8)
Iron-chelating and anti-lipid peroxidation properties of 1-(N-acetyl-6-aminohexyl)-3-hydroxy-2-methylpyridin-4-one (CM1) in long-term iron loading β-thalassemic mice. (2014) (8)
Molecular basis of βo-thalassemia/HbE disease in Thailand (1989) (8)
Deferiprone and efonidipine mitigated iron-overload induced neurotoxicity in wild-type and thalassemic mice. (2019) (8)
Pathogenesis of hypoxemia. (1992) (8)
Increased ferritin levels in non‐transfusion‐dependent β°‐thalassaemia/HbE are associated with reduced CXCR2 expression and neutrophil migration (2019) (8)
Inhibition of alpha-globin gene expression by RNAi. (2008) (8)
Comparison of Pharmacokinetics and Urinary Iron Excretion of Two Single Doses of Deferiprone in β-Thalassemia/Hemoglobin E Patients (2012) (8)
Co‐inheritance of α0‐thalassemia elevates Hb A2 level in homozygous Hb E: Diagnostic implications (2017) (8)
Three-base deletion in exon 3 of the beta-globin gene produced a novel variant (beta gunma) with a thalassemia-like phenotype. (1990) (8)
Alterations and pathology of thalassemic red cells: comparison between alpha- and beta-thalassemia. (1995) (8)
Oxidative stress and antioxidants in beta-thalassaemia/haemoglobin E. (1987) (8)
Intracranial extramedullary hematopoiesis in β°‐thalassemia/hemoglobin E disease (1981) (8)
Molecular analysis of alpha-thalassemia in Nepal: correlation with malaria endemicity. (2000) (8)
Molecular analysis of beta-thalassemia in South Vietnam. (2002) (7)
Hb G-coushatta [β22(B4)Glu→Ala] in Thailand (1999) (7)
Effects of the iron chelator deferiprone and the T-type calcium channel blocker efonidipine on cardiac function and Ca2+ regulation in iron-overloaded thalassemic mice. (2018) (7)
Difference in pattern of erythropoietin response between beta-thalassemia/hemoglobin E children and adults. (1997) (7)
Thalassemic serum inhibits endothelial cell mitosis in vitro. (1997) (7)
Effect of iron overload on furin expression in wild-type and β-thalassemic mice (2015) (7)
Detection of β-thalassemia and hemoglobin E genes in Thai by a DNA amplification technique (1989) (7)
EF Bart's disease: interaction of the abnormal alpha- and beta-globin genes. (1988) (7)
Single nucleotide polymorphisms and haplotypes of protein C and protein S genes in the Thai population (2006) (7)
Hb Siam [α1S(A13)Gly→Arg] is a GGT→CGT Mutation in the α1-Globin Gene (2000) (7)
Haemoglobin‐E trait and the clinical course of malaria in Thai soldiers (1990) (7)
Combined Iron Chelator with N-Acetylcysteine Exerts the Greatest Effect on Improving Cardiac Calcium Homeostasis in Iron-Overloaded Thalassemic Mice. (2019) (7)
Accelerated telomere shortening in β-thalassemia/HbE patients. (2015) (7)
α-Thaiassemia in Thailand (1988) (6)
High‐level induction of fetal haemoglobin by pomalidomide in β‐thalassaemia/HbE erythroid progenitor cells (2020) (6)
Vitamin E supplement improves erythrocyte membrane fluidity of thalassemia: an ESR spin labeling study. (2012) (6)
Characterization of two siderophores produced by Bacillus megaterium: A preliminary investigation into their potential as therapeutic agents. (2020) (6)
Morphological assessment of platelet activation in thalassemia. (1992) (6)
Inhibition of the acetyl lysine-binding pocket of bromodomain and extraterminal domain proteins interferes with adipogenesis. (2016) (6)
Association between promoter and coding region mutations of UDP‐glucuronosyltransferase 1A1 and β‐thalassemia/Hb E with cholelithiasis (2008) (6)
Double heterozygosity for hemoglobin E and a Lepore-type hemoglobin found in a Thai woman. (1987) (6)
Coordinated β-globin expression and α2-globin reduction in a multiplex lentiviral gene therapy vector for β-thalassemia (2021) (6)
Antioxidants as Complementary Medication in Thalassemia (2014) (6)
Applicability of a clinical scoring criteria for disease severity of ß-thalassemia/hemoglobin E in Indonesia (2018) (6)
Laboratory diagnosis for thalassemia. (1989) (6)
Study of mechanisms of post-transfusion hypertension in thalassaemic patients. (1989) (6)
Toxicity Study of a Novel Oral Iron Chelator: 1-(N-Acetyl-6-Aminohexyl)-3 Hydroxy-2-Methylpyridin-4-One (CM1) in Transgenic b-Thalassemia Mice (2013) (6)
Detection of zeta-globin chains in the cord blood by ELISA (enzyme-linked immunosorbent assay): rapid screening for alpha-thalassemia 1 (Southeast Asian type). (1998) (6)
Chicken Egg Yolk Antibodies Specific for the γ Chain of Human Hemoglobin for Diagnosis of Thalassemia (2006) (6)
Erythroblast- and erythrocyte-bound antibodies in alpha and beta thalassaemia syndromes. (1991) (6)
Genotype-Phenotype Correlation of β-Thalassemia in Malaysian Population: Toward Effective Genetic Counseling (2020) (6)
Iron chelation therapy with deferiprone improves oxidative status and red blood cell quality and reduces redox-active iron in β-thalassemia/hemoglobin E patients. (2021) (6)
The Signaling Pathways of Erythropoietin and Interferon-γ Differ in Preventing the Apoptosis of Mature Erythroid Progenitor Cells (2003) (5)
ASSOCIATION OF Hb HOPE [β136(H14)Gly → Asp] AND Hb H DISEASE (2001) (5)
Different molecular defects of Gγ (Aγδβ)°‐thalassaemia in Thailand (1987) (5)
b-Globin gene cluster polymorphisms are strongly associated with severity (2007) (5)
Electron microscopic study of liver tissue from 30 thalassemic patients. (1988) (5)
Cardiomyocyte ultrastructural damage in β‐thalassaemic mice (2013) (5)
Genome-Wide Transcriptional Regulation of the Long Non-coding RNA Steroid Receptor RNA Activator in Human Erythroblasts (2020) (5)
Lymphocytes in beta-thalassemia/HbE: subpopulations and mitogen responses. (1996) (5)
Cord blood study on β‐thalassemia and hemoglobin E (1988) (5)
Iron distribution and histopathological study of the effects of deferoxamine and deferiprone in the kidneys of iron overloaded β-thalassemic mice. (2016) (5)
Comparative Plasma Protein Profiling of Hemoglobin H Disease (2014) (5)
Cord blood study on β‐thalassemia and hemoglobin E (1988) (5)
Hemoglobin Dhonburi alpha 2 beta 2 126 (H4) Val----Gly: a new unstable beta variant producing a beta-thalassemia intermedia phenotype in association with beta zero-thalassemia. (1990) (5)
Identification of HBC [ß6(A3)GLU→LYS] in a Thai Male (1993) (5)
Heterogeneity of the gamma-globin gene sequences in Japanese individuals: implication of gene conversion in generation of polymorphisms. (1989) (5)
Study of hematopoietic progenitors in patients with thalassemia: the effect of splenectomy. (1988) (5)
Characterization of a novel deletion causing (deltabeta)0-thalassemia in a Thai family. (2007) (4)
Non-Transfusion-Dependent Thalassemia: A Complex Mix of Genetic Entities Yet to Be Fully Discovered (2015) (4)
Morphology and Kinetics of Erythropoiesis in Haemoglobin H Disease (1981) (4)
DOUBLE HETEROZYGOSITY FOR Hb PYRGOS [β83(EF7)Gly→Asp] AND Hb E [β26(B8)Glu→Lys] FOUND IN ASSOCIATION WITH α-THALASSEMIA (2002) (4)
Micromapping of Thalassemia and Hemoglobinopathies Among Laos, Khmer, Suay and Yer Ethnic Groups Residing in Lower Northeastern Thailand (2020) (4)
Interleukin-1 beta and tumor necrosis factor-alpha induced apoptosis via caspase in leukemic K 562 and HL-60 cell lines (2011) (4)
Chemical Analysis, Toxicity Study, and Free-Radical Scavenging and Iron-Binding Assays Involving Coffee (Coffea arabica) Extracts (2021) (4)
Characterization of a novel deletion causing (δβ)0‐thalassemia in a Thai family (2007) (4)
Inhibitory effect of beta zero-thalassaemia/haemoglobin E erythrocytes on Plasmodium falciparum growth in vitro. (1987) (4)
Determination of variable severity of anemia in thalassemia: erythrocyte proteolytic activity. (1987) (4)
Hematologic Changes in α-Thalassemia (1988) (4)
Molecular basis of beta-thalassemia in Thailand. (1987) (4)
Rescued Mice with Hb E Transgene‐Developed Red Cell Changes Similar to Human β‐Thalassemia/HbE Disease (2005) (4)
Genotypes and Phenotypes of Thalassemia: A Discussion (2005) (4)
Hepcidin suppression in β-thalassemia is associated with the down-regulation of atonal homolog 8 (2017) (4)
Alpha-thalassemia in Thailand. (1988) (4)
Different severity of homozygous β-thalassemia among siblings (1987) (4)
Two Cases of Compound Heterozygosity for Hb Hekinan [α27(B8)Glu→Asp (α1)] and α‐Thalassemia in Thailand (2004) (4)
Beta-globin gene haplotypes in some minor ethnic groups in Thailand. (1997) (4)
MicroRNA-Ago2 Complex in Mature Human Red Blood Cells. (2009) (4)
Elevated levels of circulating monocytic myeloid derived suppressor cells in splenectomised β‐thalassaemia/HbE patients (2020) (4)
Multiple Oral Therapeutics Suppress Repressors (LSD-1, HDACs, and BCL11A) of Gamma Globin Gene Expression (2014) (4)
Dysregulation of ferroportin gene expression in β0-thalassemia/Hb E disease (2016) (4)
Oxidative stress and antioxidants in beta-thalassemia/hemoglobin E. (1987) (4)
p53 and nitric oxide are involved in cytokine-induced apoptosis in Kasumi-1 and Molt-4 Leukemics cells. (2013) (4)
The LXCXE Retinoblastoma Protein-Binding Motif of FOG-2 Regulates Adipogenesis. (2017) (4)
Compound heterozygosity for Hb Korle-Bu (beta(73); Asp-Asn) and Hb E (beta(26); Glu-Lys) with a 3.7-kb deletional alpha-thalassemia in Thai patients. (2002) (3)
Combination Treatments of 1-(N-Acetyl-6-Aminohexyl)-3-Hydroxy-2-Methylpyridin-4-One (CM1) With Deferiprone and Desferrioxamine Reduced Labile Iron Pool and Protected Oxidative Stress in Iron-LoadedCultured Hepatocytes (2013) (3)
The fate of excess beta-globin chains within erythropoietic cells in alpha-thalassaemia 2 trait, alpha-thalassaemia 1 trait, haemoglobin H disease and haemoglobin Q-H disease: an electron microscope study. (1984) (3)
Double heterozygosity of the beta-Malay and a novel beta-thalassemia gene in a Thai patient. (1991) (3)
Viral infections in beta-thalassemia/hemoglobin E patients. (1987) (3)
Chicken egg yolk antibodies specific for the gamma chain of human hemoglobin for diagnosis of thalassemia. (2006) (3)
Studies of erythropoietic cells in heterozygotes and homozygotes for haemoglobin Constant Spring and in heterozygotes for both haemoglobin Constant Spring and alpha-thalassaemia 1 trait: extent of globin chain precipitation and cell cycle distribution. (1986) (3)
Biophysical changes of red cells with thalassemia-like abnormal hemoglobin. (1992) (3)
Differential expression of erythrocyte calpain and calpastatin activities in beta 0-thalassemia/Hb E disease. (1987) (3)
Hb Q-Thailand [alpha 74(EF3)Asp-->His]: gene organization, molecular structure, and DNA diagnosis. (1992) (3)
Decreased heat stability found in purified hemoglobin Queens [alpha 34(B15)Leu----Arg]. (1987) (3)
Identification of HB Anantharaj [α11(A9)LYS→GLU] AS HB J-Uenchang-Wuming [α11(A9)LYS→GLN] (1993) (3)
Hb SIAM [α15(A13)Gly → Arg (α1) (GGT → CGT)] IS A TYPICAL α CHAIN HEMOGLOBINOPATHY WITHOUT AN α-THALASSEMIC EFFECT (2002) (3)
Lung function tests in splenectomized beta-thalassemia/Hb E patients. (1987) (3)
Down-regulated micrornas in plasma and red blood cells of patients with malaria infection (2015) (3)
Prenatal diagnosis for beta-thalassemia syndromes using HRP-labeled oligonucleotide probes at Siriraj Hospital. (1995) (3)
Pharmacokinetics and pharmacodynamics of single dose of inhaled nebulized sodium nitrite in healthy and hemoglobin E/β-thalassemia subjects. (2019) (3)
Modulation of hepcidin expression by normal control and beta0-thalassemia/Hb E erythroblasts (2018) (3)
Decreased Heat Stability Found in Purified Hemoglobin Queens [α34(B15)Leu→Arg] (1987) (3)
Consumption of Sinlek Rice Drink Improved Red Cell Indices in Anemic Elderly Subjects (2021) (3)
A pharmacokinetic study of paracetamol in Thai β-thalassemia/HbE patients (2006) (3)
Iron homeostasis in a mouse model of thalassemia intermedia is altered between adolescence and adulthood (2020) (3)
Impact of the detection of ζ-globin chains and hemoglobin Bart’s using immunochromatographic strip tests for α0-thalassemia (--SEA) differential diagnosis (2019) (3)
Hematologic changes in alpha-thalassemia. (1988) (3)
Prenatal diagnosis of the fetus at risk for beta-thalassemia/hemoglobin E disease: a report of the first case in Thailand. (1987) (3)
Expression of betaE and gamma-globin genes in infants heterozygous for hemoglobin E and double heterozygous for hemoglobin E and alpha-thalassemia. (2007) (2)
Hb G-Coushatta [beta22(B4)Glu-->Ala] in Thailand. (1999) (2)
Report on the Proceedings of the 15th International Conference on Oral Chelation (ICOC) in the Treatmentof Thalassemia and Other Diseases at Taichung, Taiwan, April 22–26, 2005 (2006) (2)
Expression of βE and γ-globin genes in infants heterozygous for hemoglobin E and double heterozygous for hemoglobin E and α-thalassemia (2007) (2)
Simple non-radioactive method for detecting Hb Constant Spring gene (1990) (2)
THE HETEROGENEITY OF THALASSEMIA IN SOUTHEAST ASIA (2001) (2)
Two cases of compound heterozygosity for Hb Hekinan [alpha27(B8)Glu-->Asp (alpha1)] and alpha-thalassemia in Thailand. (2004) (2)
Cytotoxicity and Apoptogenic Activity of A Novel Synthetic Iron Chelator 1-(N-Acetyl-6-Aminohexyl)-3-Hydroxy-2-Methylpyridin-4-One (CM1) In Human Leukemic Cells (2013) (2)
A single nucleotide deletion in codon 123 of the beta-globin gene causes an inclusion body beta-thalassaemia trait: a novel elongated globin chain beta Makabe. (1990) (2)
Monoclonal antibody immunoassay for the identification of hemoglobin variants in neonatal screening (1994) (2)
Hb Siam [alpha15(A13)Gly-->Arg (alpha1) (GGT-->CGT)] is a typical alpha chain hemoglobinopathy without an alpha-thalassemic effect. (2002) (2)
Lysine-specific histone demethylase 1 inhibition enhances robust fetal hemoglobin induction in human β0-thalassemia/hemoglobin E erythroid cells (2021) (2)
Identification of Hb J-Buda [α61(E10)Lys→Asn] in a thai female (1999) (2)
pHCR: a Parallel Haplotype Configuration Reduction algorithm for haplotype interaction analysis (2009) (2)
Improved technic for detecting intraerythrocytic inclusion bodies in alpha thalassemia trait. (1985) (2)
Role of interleukin-3 and signaling pathways on beta-thalassemia/HbE erythroid progenitor cell in culture. (2007) (2)
Liver tissue injury secondary to iron overload in beta-thalassemia/hemoglobin E disease. (1992) (2)
Modification of platelet shape change parameter by oxidized lipoprotein from beta-thalassemia/Hemoglobin E. (2009) (2)
Establishment of MUi009 - A human induced pluripotent stem cells from a 32year old male with homozygous β°-thalassemia coinherited with heterozygous α-thalassemia 2. (2017) (2)
Genomic Study in β-Thalassemia (2011) (2)
Heterogeneity of beta thalassaemia in Thailand. (1982) (2)
Association of Hb Hope [beta136(H14)Gly-->Asp] and Hb H disease. (2001) (2)
Identification of Hb Anantharaj [alpha 11(A9)Lys->Glu] as Hb J-Wenchang-Wuming [alpha 11(A9)Lys->Gln]. (1993) (2)
Expression of hemoglobin E in newborn. (1995) (2)
Clinical Severity of β-thalassaemia/Hb E Disease Is Associated with Differential Activities of the Calpain-Calpastatin Proteolytic System (2012) (2)
Production, iron analysis and consumer perception of functional Thai Sinlek iron rice ( Oryza sativa ) drink (2020) (2)
Predictive SNPs for β0-thalassemia/HbE disease severity (2021) (2)
Hemoglobin‐bound platelets correlate with the increased platelet activity in hemoglobin E/β‐thalassemia (2020) (2)
Iron Overload in Transfusion-Dependent Indonesian Thalassemic Patients (2021) (2)
Laboratory diagnosis of a compound heterozygosity for Hb Hekinan [alpha27(B8) Glu-Asp] and a deletional alpha-thalassaemia 2 in Thailand. (2004) (2)
Relative proteome quantification of alpha, beta, gamma and delta globin chains in early eluting peaks of Bio-Rad variant II® CE-HPLC of hemoglobin from healthy and beta-thalassemia subjects in Malaysia (2019) (2)
A Phase 2 Trial of HQK-1001 (sodium 2,2-dimethylbutyrate), an Oral Fetal Globin Gene Inducer, in HbE-Beta Thalassemia in Thailand (2012) (1)
Pre-Analytical Modification of Serum miRNAs: Diagnostic Reliability of Serum miRNAs in Hemolytic Diseases (2021) (1)
Immunostick Test for Detecting ζ-Globin Chains and Screening of the Southeast Asian α-Thalassemia 1 Deletion (2019) (1)
Effect of human beta-globin bacterial artificial chromosome transgenesis on embryo cryopreservation in mouse models. (2010) (1)
Cord blood study on beta-thalassemia and hemoglobin E. (1988) (1)
Glycated Albumin Detection Using Electrochemical Aptasensor for Screening and Monitoring of Diabetes Mellitus (2017) (1)
Quadrupole-Time-of-Flight Mass Spectrometric Identification of Hemoglobin Subunits α, β, γ and δ in Unknown Peaks of High Performance Liquid Chromatography of Hemoglobin in β-Thalassemias (2019) (1)
Icsh activities and Asia. (1999) (1)
Impaired Terminal Erythroid Maturation in β0-Thalassemia/HbE Patients with Different Clinical Severity (2022) (1)
Hb Kurosaki [α7(A5)Lys → Glu (AAG →GAG)]: An α2-Globin Gene Mutation Found in Thailand (2005) (1)
Genetic Analysis of Candidate Modifier Polymorphisms in β-Thalassemia/Hb E Patients. (2004) (1)
Oropharyngeal colonization with aerobic bacteria in beta-thalassemia/hemoglobin E disease. (1987) (1)
Thai G gamma (A gamma delta beta)zero-thalassemia and its interaction with a single gamma-globin gene on a chromosome carrying beta zero-thalassemia. (1990) (1)
Nutraceutical Benefits of Green Tea in Beta-Thalassemia with Iron Overload (2020) (1)
CLINICAL FACTORS AFFECTING NTBI LEVELS: INSIGHTS FROM DIFFERENCES BETWEEN A NOVEL FLUORESCENT BEAD METHOD AND THE ESTABLISHED NTA METHOD (2016) (1)
An in vitro study on thalassemic erythroid precursors in liquid culture. (1997) (1)
Double heterozygosity for Hb Pyrgos [beta83(EF7)Gly-->Asp] and Hb E [beta26(B8)Glu-->Lys] found in association with alpha-thalassemia. (2002) (1)
RED CELLS Impairment of Plasmodium falciparum Growth in Thalassemic Red Blood Cells : Further Evidence by Using Biotin Labeling and Flow Cytometry (1999) (1)
Intracranial extramedullary hematopoiesis in beta-thalassemia/hemoglobin E disease. (1981) (1)
Molecular mechanism of β-thalassaemia caused by 22-bp duplication (2008) (1)
Green Tea: Just a Drink or Nutraceutical (2014) (1)
Hypoxemia in thalassemia. (1992) (1)
RED CELL AND PLASMA CALCIUM, COPPER AND ZINC IN ~-THALASSEMIAlHEMOGLOBIN E (2014) (1)
A pharmacokinetic study of paracetamol in Thai beta-thalassemia/HbE patients. (2006) (1)
Correction: Hemoglobin E Prevalence among Ethnic Groups Residing in Malaria-Endemic Areas of Northern Thailand and Its Lack of Association with Plasmodium falciparum Invasion In Vitro (2016) (1)
Alpha-Thalassemia: Diversity of Clinical Phenotypes and Update on the Treatment (2022) (1)
Advances in Biomolecular Medicine : Proceedings of the 4th BIBMC (Bandung International Biomolecular Medicine Conference) 2016 and the 2nd ACMM (ASEAN Congress on Medical Biotechnology and Molecular Biosciences), October 4-6, 2016, Bandung, West Java, Indonesia (2017) (1)
Development of DNA controls for detection of β‐thalassemia mutations commonly found in Asian (2020) (1)
Different severity of homozygous beta-thalassemia among siblings. (1987) (1)
Altered structure of spectrin in the two types of hemoglobin H disease. (1987) (1)
Effect of neonatal reticulocytosis on glucose 6-phosphate dehydrogenase (G6PD) activity and G6PD deficiency detection: a cross-sectional study (2022) (1)
Globin chain turnover in reticulocytes from patients with β°‐thalassaemia/Hb E disease (1995) (1)
Searching Single Nucleotide Polymorphism Markers to Complex Diseases Using Genetic Algorithm Framework and a BoostMode Support Vector Machine (2010) (1)
MRI imaging and histopathological study of brain iron overload of β-thalassemic mice. (2019) (1)
Optimal Use of Thai Sinlek Rice (IR) Provides the Nutraceutical Effect on Erythropoiesis in Rats (2019) (1)
WITHDRAWN: Pathways of iron uptake into cardiomyocytes. (2009) (1)
Clinical Severity of β-Thalassemia Pediatric Patients in Myanmar (2022) (1)
Red blood cell microparticles in hemoglobin E disorders (2015) (1)
Compound Heterozygote for a Novel Elongated C-Terminal β-Globin Variant (HBB: c.364delG) and Hb E (HBB: c.79G>A) with Heterozygous α-Thalassemia-2 (2019) (1)
Impaired neutrophil extracellular trap formation in β-thalassaemia/HbE (2022) (1)
The molecular basis of thalassemias (1989) (1)
Identification of Hb J-Buda [alpha61(E10)Lys-->Asn] in a Thai female. (1999) (1)
Fatty liver in fasted FABP4/5 null mice is not followed by liver function deterioration (2017) (1)
Rapid differentiation of five common alpha-thalassemia genotypes by polymerase chain reaction. (2001) (1)
A comprehensive study of immune function and immunophenotyping of white blood cells from β‐thalassaemia/HbE patients on hydroxyurea supports the safety of the drug (2022) (1)
AB044. Update in the management of thalassemia. (2015) (1)
DEFERIPRONE AND EFONIDIPINE EQUALLY ATTENUATED BRAIN IRON DEPOSITION AND IRON-MEDIATED BRAIN TOXICITY IN WILD-TYPE AND THALASSEMIC MICE (2019) (1)
Genetic mModifiers of Hb E / β 0 Thalassemia Identified by a Two-Stage Genome-Wide Association Study (2010) (1)
Bam HI polymorphism of the beta A-, beta E-, and beta (0) -thalassemia genes in the Thai population. (1987) (1)
Identification of Hb C [beta 6(A3)Glu-->Lys] in a Thai male. (1993) (1)
Association of the Degree of Erythroid Expansion and Maturation Arrest with the Clinical Severity of β0-Thalassemia/Hemoglobin E Patients (2021) (1)
Influence of single nucleotide polymorphisms in the BCL11A, HBS1L-MYB intergenic region, and HBB gene cluster on the fetal hemoglobin levels in Bangladeshi patients with β-thalassemia/hemoglobin E disease (2017) (1)
Twisted Gastrulation (TWSG1) Is Expressed at Elevated Levels in Thalassemia and Regulates Bone Morphogenic Protein Signaling. (2007) (1)
Plasma renin activity in patients with beta-thalassemia hemoglobin E. (1988) (1)
In Vitro Study of Ineffective Erythropoiesis in Thalassemia: Diverse Intrinsic Pathophysiological Features of Erythroid Cells Derived from Various Thalassemia Syndromes (2018) (1)
AB045. Molecular markers for disease severity in beta thalassemia/Hb E disease (2015) (0)
Phenotypic comparison of four thalassemia model mice reconstructed from cryo-banked embryos. (2013) (0)
The morphology of redox-dye-treated HbH-containing red cells: differences between cells treated with brilliant cresyl blue, methylene blue and new methylene blue. (1985) (0)
β0サラセミア/ヘモグロビンE症を合併したタイ人患者におけるβ0‐サラセミアの病因としての新知見のフレームシフト突然変異を含む5例の希有な突然変異の同定 (1992) (0)
Neglected Tropical Diseases: The Potential Application to Monitoring by microRNAs in the Real World. (2019) (0)
Restoration of correct βIVS2-654-globin mRNA splicing and HbA production by engineered U7 snRNA in β-thalassaemia/HbE erythroid cells (2019) (0)
Inhibition of cAMP synthesis abolishes the impact of curcumin administration in the skeletal muscle of rodents (2017) (0)
Induction of fetal hemoglobin: Lentiviral shRNA knockdown of HBS1L in β0-thalassemia/HbE erythroid cells (2023) (0)
The Influence of Vitamin E on Platelet Functions and Lipid Peroxidation in β-thalassemia/ Hemoglobin E Patients (2003) (0)
Deferiprone has less benefits on gut microbiota and metabolites in high iron-diet induced iron overload thalassemic mice than in iron overload wild-type mice: A preclinical study. (2022) (0)
Thalassemia and Abnormal Hemoglobin in Nakornpathom Regional Hospital (2011) (0)
Mahidol University-ICMR Kobe University Symposium on : Recent Advance in Thalassemia Research and Related Subjects in Thailand : 25-26 July, 1991, Mahidol University, Bangkok (1991) (0)
Increased autophagy leads to decreased apoptosis during β-thalassaemic mouse and patient erythropoiesis (2022) (0)
UDP-Glucuronosyl-Transferase 1A1polymorphisms (UGT1A1*28) In Thai -Thalassemia/HB E and Healthy Volunteers: Relationships to Jaundice and Gallstone Formation (2005) (0)
Lipopolysaccharide alters iron homeostasis in both wild type and β-thalassemia mice even under parenteral iron loading (2021) (0)
Plan and Strategy for Implementation of Regional ICSH Activities (1999) (0)
Hb Kodaira II [β146(HC3)His→Gln] Detected in Thailand (2003) (0)
Effects of aerobic exercise and a high-carbohydrate diet on RBP4 expression in rat skeletal muscle (2017) (0)
Mitochondrial calcium uniporter blocker prevents cardiac mitochondrial dysfunction induced by iron overload in thalassemic mice (2012) (0)
Basal expression of erythroid regulators mrna of β-thalassemia/hb E erythroblasts: 282 (2016) (0)
Single Nucleotide Polymorphism (SNP) Discovery within the UGT1A Gene Complex: Allelic Frequencies and Ethnic Differences. (2004) (0)
Alpha-mRNA level in the two types of Hb H disease. (1987) (0)
Correlation between Serum Fatty Acid Binding Protein 4 (FABP4) Levels and Cardiac Function in Patients with Thalassemia Major (2021) (0)
The hypoferremic response to acute inflammation is maintained in thalassemia mice even under parenteral iron loading (2021) (0)
Platelet Aggregation Is Inhibited by Nitrite Reduction to Nitric Oxide In Blood (2010) (0)
Up-regulation of Fc gamma RI and its role in red cell destruction in thalassaemia (1998) (0)
Abstract 11087: T-type Calcium Channel is a Main Portal for Iron Entry in Thalassemic Heart (2010) (0)
Mapping of health care facilities in the universal coverage era at Bandung District, Indonesia (2017) (0)
Constant Spring mutation fluorescence polymerase chain reaction to detect the hemoglobin Asymmetrically primed selective amplification/temperature shift (2011) (0)
In vivo model systems for therapeutic approaches to β-thalassemia (2007) (0)
Histone Modification Levels are Correlated with the Severity of -Thalassemia/Hbe Patients (2018) (0)
Can we measure iron overload in the heart using in vivo MRI T2*? (2009) (0)
Evidence for Three Distinct Classes of Phenotype Severity in Beta-Thalassaemia (2019) (0)
Chapter 19 Green Tea : Just a Drink or Nutraceutical (2017) (0)
The Pharmacokinetics Study of Paracetamol And Its Metabolites in Thalassemic Patients (2004) (0)
Circulating microRNAs in malaria infection: bench to bedside (2017) (0)
Global Globin Network Consensus Paper: Classification and Stratified Roadmaps for Improved Thalassaemia Care and Prevention in 32 Countries (2022) (0)
Abstracts: Basic Science in arrhythmias: mechanisms (2009) (0)
P59. Platelet aggregation is inhibited by nitrite reduction to nitric oxide in blood (2011) (0)
Recent advances in thalassemia research and related subjects in Thailand : 25-26 July, 1991, Mahidol University, Bangkok (1992) (0)
Corrigendum to "Deferiprone and efonidipine mitigated iron-overload induced neurotoxicity in wild-type and thalassemic mice" [Life Sci. 239 (2019) 116878]. (2023) (0)
Effects of green tea extract treatment on erythropoiesis and iron parameters in iron-overloaded β-thalassemic mice (2022) (0)
Nitrite Inhibits Platelet Reactivity in Presence of Deoxygenated Red Blood Cells As Measured by Flow Cytometry (2012) (0)
Effect of Tumor Necrosis Factor-Alpha on Erythropoietin- and Erythropoietin Receptor-Induced Erythroid Progenitor Cell Proliferation in β-Thalassemia/Hemoglobin E Patients β-Talasemi/Hemoglobin E Hastalarinda Tümör Nekrozlaştirici Faktör-Alfa'nin Eritropoetin- ve Eritropoetin Reseptör- ile Uyarilmiş (2014) (0)
PlO : THE PHARMACOKINETICS STUDY OF PARACETAMOL AND ITS MET ABO LITES IN THALASSEMIC PATIENTS 67 (2015) (0)
A comprehensive ethnic-based analysis of alpha thalassaemia allelle frequency in northern Thailand (2017) (0)
Comparison oferythrocyte antioxidative enzyme activities between twotypesofhaemoglobin H disease (1986) (0)
The Pharmacokinetics Study of Propanolol in Thalassemic Patients (2004) (0)
Genetic predictions of life expectancy in southern Thai patients with β0-thalassemia/Hb E (2022) (0)
7 Genomic Study in β-Thalassemia (2018) (0)
Prevention and Control of Thalassemia in Thailand (2012) (0)
Searching for Disease Modifiers Genes in Thalassemia. (2005) (0)
Lung perfusion in thalassemia. (1987) (0)
Ethnic Differences in Polymorphisms and Haplotypes within the UGT1A Gene Complex. (2004) (0)
Abstract 9422: T-Type Calcium Channel Inhibitor Attenuates Cardiac Dysfunction, Improves Cardiac Sympathovagal Imbalance and Decreases Mortality in Iron-Overloaded Mice (2011) (0)
Generation of human induced pluripotent stem cell line (MUi034-A) from an unusual case of hydrops fetalis associated with homozygous hemoglobin Constant Spring. (2022) (0)
Diagnostic Modalities in Detecting Cardiovascular Complications of Thalassemia (2022) (0)
Contents Vol. 126, 2011 (2011) (0)
Immunostick Test for Detecting ζ-Globin Chains and Screening of the Southeast Asian α-Thalassemia 1 Deletion (2019) (0)
Introduction to the Special Issue (2022) (0)
A FLOW–CYTOMETRIC ANALYSIS OF THE INHIBITION OF PLATELET REACTIVITY WITH NITRITE REDUCTION BY DEOXYGENATED ERYTHROCYTES (2013) (0)
Proceedings of the PSU-ICMR symposium : health in southern thailand, genetics and thalassemia, 25-26 July 1996, Songkhla, Thailand (1997) (0)
Overview of Thalassemia Services in Thailand (2019) (0)
INVITED SPEAKERS: I-4: GENETIC MODIFIERS IN BETA-THALASSEMIA (2011) (0)
Diet-Related Thalassemia Associated with Iron Overload (2020) (0)
Structural analysis of proteins in Thailand: Identification of abnormal hemoglobins (1994) (0)
Icplm – Speakers’ Abstracts (2005) (0)
Characterization of 14-3-3β Expression during Differentiation of the Megakaryocytic Cell Line MEG-01 (2008) (0)
I-4: Genetic Modifiers in Beta-Thalassemia (2011) (0)
T-TYPE CALCIUM CHANNEL BLOCKER EXERTS SIMILAR EFFICACY AS IRON CHELATORS IN ATTENUATING CARDIOVASCULAR AND MITOCHONDRIAL DYSFUNCTION IN IRON-OVERLOAD THALASSEMIC MICE (2015) (0)
Chromosomal microarray analysis in a cohort of underrepresented population identifies SERINC2 as a novel candidate gene for autism spectrum disorder (2017) (0)
Plasmodium falciparum invasion with abnormal hemoglobins and relation with susceptibility to Reduced deformability of thalassemic erythrocytes and erythrocytes (2011) (0)
The effects of vitamin E on platelet activity in b-thalassaemia (2003) (0)
Studies of Oxidative Stress Induced Damage on Lipoproteins in β-Thalassemia/Hemoglobin E. (2004) (0)
Proceedings of the UI-ICMR Symposium : first asian colloquium on standardization in laboratory medicine : (standardization and harmonization of laboratory testing in Asia) (1999) (0)
Development of fluorescence-based genomic reporter assay for high-throughput screening of potential fetal haemoglobin inducers (2007) (0)
Effects of thalassaemic serum on the in vitro development of the malarial parasitePlasmodium falciparum (2004) (0)
Derivation of the human induced pluripotent stem cell line MUi017-A from a patient with homozygous Hemoglobin Constant Spring. (2017) (0)
Title : ICSH Recommendations for Assessing Automated High Performance Liquid Chromatography and Capillary Electrophoresis equipment for the Quantitation of HbA 2 Running Title Assessing Automated HPLC and CE for HbA 2 Writing Group (0)
Effects of selenium on SePP and Apo B-100 Gene expressions in human primary hepatocytes (2017) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Suthat Fucharoen?

Suthat Fucharoen is affiliated with the following schools:

Suthat Fucharoen's Academic­Influence.com Rankings

Suthat Fucharoen's Degrees

Why Is Suthat Fucharoen Influential?

Suthat Fucharoen's Published Works

Published Works

What Schools Are Affiliated With Suthat Fucharoen?

Suthat Fucharoen's AcademicInfluence.com Rankings